| Abstrakt: |
QUÉBEC CITY, Dec. 4, 2017 /CNW Telbec/ - Microbiologist and researcher Gary Kobinger received the Ernest C. Manning Innovation Awards' Principal Award in Toronto on November 29, in recognition of the treatment he developed, trademarked ZMapp, for Ebola virus disease, a severe and often fatal infection. Dr. Kobinger is the director of the Québec City–Université Laval Hospital Research Centre's CRI Infectious Disease Research Centre as well as a professor with Université Laval's Faculty of Medicine and a world authority in vaccine research. He shares the award with his research partner Dr. Qui Xiangguo of Winnipeg. [ABSTRACT FROM PUBLISHER] |
